secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2026-05-26T12:00:24+00:00
Accession:  0001437749-26-018317
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin posts corporate presentation on website; no new material details disclosed
--------------------------------------------------------------------------------

- Presentation dated May 2026 made available on company website.
- No financial results, clinical updates, or guidance provided in the filing.
- Presentation content is an image exhibit; no specific data extracted.
- This is a routine disclosure; no material changes to company outlook.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926018317/0001437749-26-018317-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774926018317/mbrx20260522c_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-018317

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer